| Year |
Citation |
Score |
| 2022 |
Sathyasaikumar KV, Pérez de la Cruz V, Pineda B, Vázquez Cervantes GI, Ramírez Ortega D, Donley DW, Severson PL, West BL, Giorgini F, Fox JH, Schwarcz R. Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma. Antioxidants (Basel, Switzerland). 11. PMID 35204197 DOI: 10.3390/antiox11020315 |
0.648 |
|
| 2021 |
Griffith SM, Gigley J, Fox J, Bangoura B. Identification and characterization of Eimeria spp. in western north American Bison (Bison bison) herds and potential risk of cross-species transmission. Veterinary Parasitology, Regional Studies and Reports. 26: 100627. PMID 34879938 DOI: 10.1016/j.vprsr.2021.100627 |
0.553 |
|
| 2021 |
Donley DW, Realing M, Gigley JP, Fox JH. Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease. Plos One. 16: e0250606. PMID 33989290 DOI: 10.1371/journal.pone.0250606 |
0.598 |
|
| 2019 |
Baskaran P, Markert L, Bennis J, Zimmerman L, Fox J, Thyagarajan B. Assessment of Pharmacology, Safety, and Metabolic activity of Capsaicin Feeding in Mice. Scientific Reports. 9: 8588. PMID 31197191 DOI: 10.1038/S41598-019-45050-0 |
0.314 |
|
| 2018 |
Agrawal S, Fox J, Thyagarajan B, Fox J. Brain mitochondrial iron accumulates in Huntington's disease, mediates mitochondrial dysfunction, and can be removed pharmacologically. Free Radical Biology & Medicine. PMID 29625173 DOI: 10.1016/J.Freeradbiomed.2018.04.002 |
0.404 |
|
| 2017 |
Berggren K, Agrawal S, Fox JA, Hildenbrand J, Nelson R, Bush AI, Fox JH. Amyloid Precursor Protein Haploinsufficiency Preferentially Mediates Brain Iron Accumulation in Mice Transgenic for The Huntington's Disease Mutation. Journal of Huntington's Disease. PMID 28550267 DOI: 10.3233/Jhd-170242 |
0.379 |
|
| 2017 |
Agrawal S, Berggren KL, Marks E, Fox JH. Impact of high iron intake on cognition and neurodegeneration in humans and in animal models: a systematic review. Nutrition Reviews. PMID 28505363 DOI: 10.1093/nutrit/nux015 |
0.304 |
|
| 2016 |
Donley DW, Olson AR, Raisbeck MF, Fox JH, Gigley JP. Huntingtons Disease Mice Infected with Toxoplasma gondii Demonstrate Early Kynurenine Pathway Activation, Altered CD8+ T-Cell Responses, and Premature Mortality. Plos One. 11: e0162404. PMID 27611938 DOI: 10.1371/Journal.Pone.0162404 |
0.589 |
|
| 2016 |
Berggren KL, Lu Z, Fox JA, Dudenhoeffer M, Agrawal S, Fox JH. Neonatal Iron Supplementation Induces Striatal Atrophy in Female YAC128 Huntington's Disease Mice. Journal of Huntington's Disease. 5: 53-63. PMID 27079948 DOI: 10.3233/JHD-150182 |
0.382 |
|
| 2015 |
Fox J, Lu Z, Barrows L. Thiol-disulfide Oxidoreductases TRX1 and TMX3 Decrease Neuronal Atrophy in a Lentiviral Mouse Model of Huntington's Disease. Plos Currents. 7. PMID 26664998 DOI: 10.1371/Currents.Hd.B966Ec2Eca8E2D89D2Bb4D020Be4351E |
0.411 |
|
| 2015 |
Berggren KL, Chen J, Fox J, Miller J, Dodds L, Dugas B, Vargas L, Lothian A, McAllum E, Volitakis I, Roberts B, Bush AI, Fox JH. Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease. Redox Biology. 4: 363-74. PMID 25703232 DOI: 10.1016/J.Redox.2015.02.002 |
0.474 |
|
| 2014 |
Lu Z, Marks E, Chen J, Moline J, Barrows L, Raisbeck M, Volitakis I, Cherny RA, Chopra V, Bush AI, Hersch S, Fox JH. Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model. Neurobiology of Disease. 71: 34-42. PMID 25014023 DOI: 10.1016/J.Nbd.2014.06.022 |
0.392 |
|
| 2014 |
Dodds L, Chen J, Berggren K, Fox J. Characterization of Striatal Neuronal Loss and Atrophy in the R6/2 Mouse Model of Huntington's Disease. Plos Currents. 6. PMID 24459614 DOI: 10.1371/Currents.Hd.48727B68B39B82D5Fe350F753984Bcf9 |
0.32 |
|
| 2013 |
Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, Volitakis I, Bush AI, Hersch S, Fox JH. Iron accumulates in Huntington's disease neurons: protection by deferoxamine. Plos One. 8: e77023. PMID 24146952 DOI: 10.1371/Journal.Pone.0077023 |
0.34 |
|
| 2012 |
Rosas HD, Chen YI, Doros G, Salat DH, Chen NK, Kwong KK, Bush A, Fox J, Hersch SM. Alterations in brain transition metals in Huntington disease: an evolving and intricate story. Archives of Neurology. 69: 887-93. PMID 22393169 DOI: 10.1001/Archneurol.2011.2945 |
0.35 |
|
| 2010 |
Fox JH, Connor T, Chopra V, Dorsey K, Kama JA, Bleckmann D, Betschart C, Hoyer D, Frentzel S, Difiglia M, Paganetti P, Hersch SM. The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease. Molecular Neurodegeneration. 5: 26. PMID 20569486 DOI: 10.1186/1750-1326-5-26 |
0.311 |
|
| 2007 |
Fox JH, Kama JA, Lieberman G, Chopra R, Dorsey K, Chopra V, Volitakis I, Cherny RA, Bush AI, Hersch S. Mechanisms of copper ion mediated Huntington's disease progression. Plos One. 2: e334. PMID 17396163 DOI: 10.1371/Journal.Pone.0000334 |
0.356 |
|
| 2004 |
Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, Buzescu R, Chopra R, Ferrante RJ, Kazantsev A, Hersch SM. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. Journal of Neurochemistry. 91: 413-22. PMID 15447674 DOI: 10.1111/J.1471-4159.2004.02726.X |
0.324 |
|
| Show low-probability matches. |